If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
5,040.00    -45.00 (-0.88%)
Bid:
5,035.00
Ask:
5,040.00
Spread: 5.00 (0.099%)
Market Cap: £2.35b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

AGM Voting Update

4 Sep 2023 12:51

RNS Number : 3096L
Morgan Sindall Group PLC
04 September 2023
 

Morgan Sindall Group plc

Legal Entity Identifier (LEI) number: 2138008339ULDGZRB345

 

4 September 2023

Morgan Sindall Group plc ("the Company")

 

Update on response to 2023 AGM voting outcome

 

At our Annual General Meeting ('AGM') held on 4 May 2023, resolution 3 (Approval of the Directors' Remuneration Policy) was supported by a large majority of shareholders but received less than 80% support overall.

 

In advance of the 2023 AGM, the Remuneration Committee (the 'Committee') undertook a detailed engagement with the Company's largest shareholders in relation to the remuneration proposals, and had amended the final Remuneration Policy design in response to feedback received. Following the 2023 AGM, the Committee reached out to the Company's largest shareholders to continue the dialogue and listen to their views - and in particular to understand why those who either abstained or voted against the Directors' Remuneration Policy ('the 'Policy') had done so.

 

The Committee received responses from eight investors, the majority of whom reconfirmed support for the Policy and the management team. 

 

One shareholder raised the annual bonus deferral requirement and 2nd-year phasing down of the post-employment shareholding requirement as their reason for not supporting the resolution. In both cases the Committee is comfortable that its current approach supports appropriate alignment of executive and shareholder interests. In respect of the annual bonus deferral requirement, the Committee also considers this requirement appropriate given the current shareholdings of incumbent Executive Directors. However, the Committee will reconsider both of these Policy design features as part of the next Policy review.

 

The Committee also received feedback from two shareholders that their voting had reflected the 'against' recommendation from one of the major proxy voting agencies, which itself was primarily a result of the simultaneous increases to the Policy headroom available under the annual bonus and LTIP schemes. On this matter, the Committee maintains its view that the Policy should be sufficiently flexible to last for a full triennial review period rather than needing to revert to shareholders to seek incremental changes, and reiterates its commitment to write out to major shareholders in advance of using the increased maximum opportunities under either of the variable incentives.

 

Another shareholder requested that the Committee provide a full explanation in its Remuneration Report of the rationale for the adoption of any increase to the executive directors' incentive opportunities in future years, particularly in relation to the achievement of key strategic objectives, and this feedback is consistent with the current thinking of the Committee.

 

The Committee continues to be grateful for the feedback received and the two-way engagement with major shareholders. Given overall majority support was obtained for the Policy resolution, it is not proposed to make any further changes to the approach to remuneration that was set out in the 2022 Annual Report. The Company will, however, continue to keep the Policy under review over the coming years and welcomes ongoing dialogue with shareholders and proxy advisers.

 

 

Enquiries:

Clare Sheridan, Company Secretary +44 (0) 20 7307 9200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZLFBXKLEBBF
Date   Source Headline
20th Nov 20187:00 amRNSSenior Management Forum
16th Nov 20182:53 pmRNSDirector/PDMR Shareholding
1st Nov 20187:00 amRNSTrading Update
29th Oct 201811:30 amRNSNotice of Trading Update
22nd Oct 20189:01 amRNSBlock listing Interim Review
9th Oct 20184:08 pmRNSHolding(s) in Company
1st Oct 201810:08 amRNSTotal Voting Rights
28th Sep 20183:47 pmRNSHolding(s) in Company
27th Sep 20188:00 amRNSDirectorate Change
24th Sep 20188:18 amRNSHolding(s) in Company
4th Sep 20184:15 pmRNSHolding(s) in Company
3rd Sep 201812:02 pmRNSHolding(s) in Company
3rd Sep 20189:25 amRNSTotal Voting Rights
14th Aug 20187:00 amRNSDirectorate Change
8th Aug 20187:00 amRNSHalf-year Report
3rd Aug 20183:10 pmRNSHolding(s) in Company
1st Aug 20189:47 amRNSTotal Voting Rights
11th Jul 20183:16 pmRNSHolding(s) in Company
11th Jul 20187:00 amRNSNotice of Results
2nd Jul 201811:31 amRNSTotal Voting Rights
4th Jun 20184:34 pmRNSHolding(s) in Company
1st Jun 20184:30 pmRNSTotal Voting Rights
16th May 20188:00 amRNSAdditional Listing
4th May 201812:37 pmRNSResult of AGM
4th May 20187:00 amRNSAGM Trading Update
30th Apr 201810:17 amRNSTotal Voting Rights
23rd Apr 20189:15 amRNSBlock listing Interim Review
17th Apr 20187:00 amRNSMorgan Sindall Group Agrees £2bn Joint Venture
29th Mar 20185:29 pmRNSTotal Voting Rights
26th Mar 201812:25 pmRNSAnnual Financial Report
20th Mar 20182:38 pmRNSHolding(s) in Company
7th Mar 20189:28 amRNSDirector/PDMR Shareholding
7th Mar 20189:27 amRNSDirector/PDMR Shareholding
5th Mar 20183:49 pmRNSDirector/PDMR Shareholding
28th Feb 201811:19 amRNSTotal Voting Rights
26th Feb 20189:43 amRNSHolding(s) in Company
22nd Feb 20187:00 amRNSFinal Results
1st Feb 201810:45 amRNSTotal Voting Rights
30th Jan 20182:33 pmRNSHolding(s) in Company
29th Jan 20183:10 pmRNSDirectorate Change
15th Jan 201812:38 pmRNSStatement re: Carillion plc
8th Jan 20187:00 amRNSNotice of Results
3rd Jan 20189:08 amRNSTotal Voting Rights
14th Dec 20178:00 amRNSAdditional Listing
1st Dec 20171:00 pmRNSTotal Voting Rights
1st Dec 201712:37 pmRNSDirector/PDMR Shareholding
28th Nov 20175:13 pmRNSHolding(s) in Company
27th Nov 20177:00 amRNSPartnership Homes MOD Contract
24th Nov 20172:55 pmRNSHolding(s) in Company
22nd Nov 20177:00 amRNSAnalyst and Investor Evening Reception

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.